Literature DB >> 14680467

Microspheres for controlled release drug delivery.

Neelesh K Varde1, Daniel W Pack.   

Abstract

Controlled release drug delivery employs drug-encapsulating devices from which therapeutic agents may be released at controlled rates for long periods of time, ranging from days to months. Such systems offer numerous advantages over traditional methods of drug delivery, including tailoring of drug release rates, protection of fragile drugs and increased patient comfort and compliance. Polymeric microspheres are ideal vehicles for many controlled delivery applications due to their ability to encapsulate a variety of drugs, biocompatibility, high bioavailability and sustained drug release characteristics. Research discussed in this review is focused on improving large-scale manufacturing, maintaining drug stability and enhancing control of drug release rates. This paper describes methods of microparticle fabrication and the major factors controlling the release rates of encapsulated drugs. Furthermore, recent advances in the use of polymer microsphere-based systems for delivery of single-shot vaccines, plasmid DNA and therapeutic proteins are discussed, as well as some future directions of microsphere research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14680467     DOI: 10.1517/14712598.4.1.35

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  63 in total

1.  Precise control of PLG microsphere size provides enhanced control of drug release rate.

Authors:  Cory Berkland; Martin King; Amanda Cox; Kyekyoon Kim; Daniel W Pack
Journal:  J Control Release       Date:  2002-07-18       Impact factor: 9.776

2.  Microchip for sustained drug delivery by diffusion through microchannels.

Authors:  Seung Ho Lee; Min Park; Chun Gwon Park; Ji Eun Lee; Mark R Prausnitz; Young Bin Choy
Journal:  AAPS PharmSciTech       Date:  2012-01-04       Impact factor: 3.246

3.  Ion-pair chromatography for simultaneous analysis of ethionamide and pyrazinamide from their porous microparticles.

Authors:  Chintan J Bhanushali; Ahmed S Zidan; Ziyaur Rahman; Muhammad J Habib
Journal:  AAPS PharmSciTech       Date:  2013-08-30       Impact factor: 3.246

4.  Solid-phase synthesis and kinetic characterization of fluorogenic enzyme-degradable hydrogel cross-linkers.

Authors:  Jason A Moss; Shula Stokols; Mark S Hixon; Fawn T Ashley; Jason Y Chang; Kim D Janda
Journal:  Biomacromolecules       Date:  2006-04       Impact factor: 6.988

Review 5.  Inductive tissue engineering with protein and DNA-releasing scaffolds.

Authors:  David M Salvay; Lonnie D Shea
Journal:  Mol Biosyst       Date:  2005-11-25

6.  Colloidal microgels in drug delivery applications.

Authors:  Serguei V Vinogradov
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

7.  Neurons Internalize Functionalized Micron-Sized Silicon Dioxide Microspheres.

Authors:  Veronica J Wallace; Raffaello Cimbro; F Javier Rubio; Lowella V Fortuno; Julie C Necarsulmer; Pyry P Koivula; Mark J Henderson; Lindsay M DeBiase; Brandon L Warren; Brandon K Harvey; Bruce T Hope
Journal:  Cell Mol Neurobiol       Date:  2017-03-04       Impact factor: 5.046

Review 8.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

9.  Sequential release of nanoparticle payloads from ultrasonically burstable capsules.

Authors:  Stephen Kennedy; Jennifer Hu; Cathal Kearney; Hadas Skaat; Luo Gu; Marco Gentili; Herman Vandenburgh; David Mooney
Journal:  Biomaterials       Date:  2015-10-22       Impact factor: 12.479

Review 10.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Authors:  M C Gaspar; W Couet; J-C Olivier; A A C C Pais; J J S Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.